Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma

BACKGROUND: A frequent mechanism of acquired multidrug resistance in human cancers is overexpression of ATP-binding cassette transporters such as the Multi-Drug Resistance Protein 1 (MDR-1). Nutlin-3, an MDM2–p53 antagonist, has previously been reported to be a competitive MDR-1 inhibitor. METHODS:...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chen, L, Zhao, Y, Halliday, G C, Berry, P, Rousseau, R F, Middleton, S A, Nichols, G L, Del Bello, F, Piergentili, A, Newell, D R, Lunec, J, Tweddle, D A
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2014
Témata:
Translational Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4134492/
https://ncbi.nlm.nih.gov/pubmed/24921920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.325
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky